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Questions Society for Vascular Surgery Phone: 800-258-7188; education@vascularsociety.org Patients who undergo major vascular operations have an increased risk of postoperative morbidity compared with many other surgical populations. 1 When complications do occur in these patients, their effects can be profound. Postoperative morbidity is the single most important predictor of death after major surgery, surpassing even comorbid disease burden in the strength of its association with subsequent patient death. 2, 3 In addition, complications have a significant effect on health care resource utilization and increase the hospital length of stay, overall hospital costs, and need for hospital readmission. [4] [5] [6] [7] [8] It is therefore no surprise that complication prevention has become a major focus for quality improvement in vascular surgery. 9, 10 To be maximally effective, complication-related quality initiatives should target those complications that impose the greatest overall clinical and economic burden on a given surgical population. Numerous studies have been published describing the incidence of specific complications after major vascular surgery and the associations between these complications and subsequent patient outcomes. 9, [11] [12] [13] [14] To our knowledge, however, there has been no published attempt to combine this knowledge of complication frequency and severity into a global measure of overall impact. The objective of our study was therefore to estimate and compare the impacts of seven distinct postoperative complications on clinical and resource utilization outcomes after major vascular surgery.
METHODS
The analysis included patients whose data were contained within the 2012 to 2014 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Participant Use Files (PUFs). 15 The sampling strategy that is used by ACS NSQIP, the variables that are collected, and the methods that are used to ensure data quality and reliability have been previously described. 15, 16 The PUFs contain prospectively collected information on >240 perioperative variables. As of 2014, 435 hospitals participated in the ACS NSQIP program. 15 Because of the deidentified nature of this national database, the study is exempted from requirements for Institutional Review Board approval and individual informed consent. 10 The primary clinical outcome measures for our analysis included 30-day mortality and end-organ dysfunction (EOD). EOD is a composite variable intended to reflect an adverse but potentially sublethal physiologic outcome. EOD was noted to occur if a patient developed one or more of the following conditions in the first 30 days after their index vascular surgical procedure: need for postoperative mechanical ventilation >48 hours, renal insufficiency (with or without the need for hemodialysis), or septic shock.
The primary resource utilization outcome measures for our analysis included need for prolonged postoperative hospitalization and 30-day hospital readmission. We defined prolonged postoperative hospitalization as a length of postoperative hospital stay that exceeded the 75th percentile value for the type of the index procedure that the patient received (>1 day for CEA, >10 days for AAA repair, >7 days for aortoiliac reconstruction, >6 days for lower extremity bypass, and >8 days for lower extremity amputation). 17 The primary predictor variables for our analysis were the presence or absence of the following index complications #30 days after vascular surgery: surgical site infection (SSI; includes superficial incisional, deep incisional, or organ or space incisional infection), bleeding, pneumonia, venous thromboembolism (VTE; includes deep venous thrombosis or pulmonary embolism), urinary tract infection (UTI), myocardial infarction (MI), and cerebrovascular accident (CVA). Each of these complications is strictly defined by ACS NSQIP to ensure uniformity of reporting across participating hospitals, and several processes are in place to ensure the accuracy of the complications data that is submitted to ACS NSQIP by participating centers. 16 Table I . Missing information for predictor variables was handled in one of two ways. For variables in which a very small percentage of observations (<0.5%) were missing (as was the case for emergency procedure status and American Society of Anesthesiologists Physical Status classification), patients with missing data were simply excluded from the analysis. For variables in which a larger percentage of observations were lacking (as was the case for body mass index and preoperative functional status), a missing indicator category was created. 18 Patients missing information for one or more of our outcomes measures were also excluded from analysis.
The frequency of the seven index complications and five adverse outcome measures were calculated. Separate multivariable logistic regression models were created for each outcome measure to determine the association between each of the complications and subsequent patient or resource utilization outcomes. In addition to the index complications, the patient-and procedure-related characteristics that are listed in Table I were included as potential predictor variables in these regression models. Hosmer-Lemeshow and C statistics were reported for each model. We used population-attributable fractions (PAFs) to quantify the overall effect of each index complication on a given adverse outcome measure. Unadjusted PAF is calculated as PAF
where Pc represents the prevalence of the complication in the study population, and RR represents the risk ratio of the adverse outcome given the complication. 19 This parameter has traditionally been used in the epidemiologic literature to determine the amount of a given disease state that is due to a specific risk factor. Use of PAF assumes some type of causal relationship between exposure (ie, postoperative complication) and disease state (ie, adverse outcome) and also assumes that the exposure is modifiable. 20 This parameter is an attractive measure of overall complication impact because it incorporates information about the frequency of a complication and also the relative risk of an adverse outcome given the presence of that complication.
In the context of our analysis, the PAF represents the overall reduction in incidence of a given adverse outcome, such as death or hospital readmission, that would be expected in a theoretical scenario where exposure to the complication within a population was able to be completely prevented. Using data from our multivariable logistic regression models, we were able to estimated risk-adjusted PAFs (with 95% confidence intervals) for each complication-adverse outcome pair in a manner that adjusts for the other patient/ procedure factors and for the presence of other index complications. 21, 22 To account for the possibility that the five procedure types might exhibit distinct complication impact profiles, we first conducted the aforementioned statistical analyses separately for each procedure type. Inspection of the results demonstrated that the complication impact profile for CEA was substantially different than for the other four procedure types (data not shown). Our final analysis was therefore conducted on two separate groups: patients undergoing CEA and patients undergoing an open abdominal/lower extremity vascular operation, including AAA repair, aortoiliac reconstruction, lower extremity bypass, or lower extremity amputation. The multivariate logistic regression models that were used for patients undergoing abdominal/lower extremity procedures included procedure type as a potential predictor variable. Stata 14.0 software (StataCorp LP, College Station, Tex) was used for all statistical analyses.
RESULTS
A total of 72,805 vascular surgery patients from the 2012 to 2014 ACS NSQIP PUFs were available for analysis. Information was missing for emergency procedure status in 2 patients, for American Society of Anesthesiologists Physical Status classification in 87, for length of postoperative hospitalization in 64, for nonroutine hospital discharge status in 159, and for hospital readmission in 166 patients. Missing information resulted in the exclusion of 413 of available patients (0.6%), leaving a final study population of 72,392 patients.
The patient-and procedure-related characteristics of our study population are reported in Table I The most common index complications in patients undergoing CEA were bleeding (2.2%) and stroke (1.7% ;  Fig, A) . The most common index complications in patients undergoing an abdominal/lower extremity vascular operation were bleeding (30.4%) and SSI (7.1% ; Fig, B) . EOD occurred #30 days of the index operation in 346 CEA patients (1.1%) and in 2605 abdominal/lower extremity vascular patients (6.5%). Mortality at 30 days was 1.0% for CEA patients and 5.2% for abdominal/lower extremity patients. Postoperative hospitalization was prolonged in 12,036 CEA patients (37.3%) and in 10,864 abdominal/ lower extremity vascular operation patients (27.1%), and the rate of 30-day hospital readmission was 6.9% and 13.5% for these groups, respectively.
The associations between the seven index complications and 30-day clinical outcomes are reported for CEA patients in Table II , A, and for those undergoing abdominal/lower/extremity vascular operation in Table II, B. For both groups, occurrence of pneumonia was associated with the highest adjusted odds of EOD, and stroke was associated with the highest odds of death. The associations between the seven index complications and 30-day resource utilization outcomes are summarized for CEA patients in Table III , A, and for abdominal/lower extremity vascular operations in Table III , B. Stroke was the complication associated with the highest adjusted odds of prolonged hospitalization in CEA patients (Table III, A) , and pneumonia was associated with the highest odds of prolonged postoperative stay in abdominal/lower extremity vascular surgical patients (Table III, B) . For both groups, SSI was the complication that was associated with the highest adjusted odds of 30-day hospital readmission. We estimated risk-adjusted PAFs to characterize the effect of each index complication on the respective outcome measures of our study (Tables IV, A and B) .
The PAF values represent the percentage reduction in a given adverse outcome that would be expected if exposure to the specific index complication had been completely prevented in our study population. For CEA patients (Table IV, A) , pneumonia was the complication with the greatest impact on EOD, and CVA was the complication with the greatest impact on 30-day mortality. None of the index complications demonstrated a sizeable impact on the need for prolonged hospitalization or 30-day hospital readmission in patients undergoing CEA (Table IV, A) . For patients undergoing an abdominal/lower extremity vascular operation, bleeding was the complication with the greatest overall impact on EOD, mortality, and need for prolonged postoperative hospitalization (Table IV, B) . Complete prevention of bleeding in our study population would be estimated to reduce the overall incidence of EOD in these patients by 29 .0%, the incidence of mortality by 16 .3%, and the need for prolonged hospitalization by 14.9%. SSI was the only index complication to demonstrate a sizeable impact on hospital readmission in these patients, as evidenced by an adjusted PAF estimate of 21.7% (Table IV, B) .
DISCUSSION
In this study, we have used PAFs to quantify the overall impacts of seven types of postoperative complications on clinical and resource utilization outcomes after major vascular surgery. The PAF has traditionally been used in epidemiologic research to describe the contributions of risk factors to a given disease state and thus to help identify priorities for public health action. 23 In the context of our study, the PAF represents the percentage reduction in a given adverse outcome that would be anticipated if a specific complication were completely prevented.
Of the seven types of complications included for analysis, we found that bleeding, pneumonia, and CVA had the largest overall impact on clinical outcomes after major vascular operations. Complete prevention of pneumonia in our study population would result in an estimated decrease in the incidence EOD of 24.4% after CEA and of 18.1% after abdominal/lower extremity vascular surgery. Complete prevention of CVA would result in an estimated 23 .1% reduction in 30-day mortality after CEA, and prevention of bleeding would result in a 16.3% reduction in mortality after abdominal/lower extremity procedures. None of the index complications that we studied appeared to have a large impact on the resource utilization outcomes of CEA patients in our study. Conversely, bleeding and SSI demonstrated sizeable impacts on the need for prolonged hospitalization and 30-day readmission, respectively, in abdominal/lower extremity vascular surgical patients. Taken together, the findings of our study suggest that pneumonia and CVA are the complications that merit the highest prioritization as targets for quality improvement in patients undergoing CEA, and bleeding, pneumonia, and SSI are the highest-impact complications for patients undergoing major vascular or lower extremity operation. Of the four high-impact complications that our analysis identified, postoperative SSI has been the most extensively studied. Numerous reports have documented potential risk factors for infectious wound complications after vascular surgery or have generated statistical models that can be used to predict the risk of this complication. 14, [24] [25] [26] In addition, SSI is already included as an outcome measure in most prospective, national registries of vascular patients such as ACS NSQIP and the Society for Vascular Surgery Vascular Quality Initiative. 14, 15 Finally, numerous strategies for preventing SSI have been incorporated as process-of-care measures in federal quality improvement initiatives such as the Surgical Care Improvement Project (SCIP). 27 Although the ability of these process measures to effect meaningful reductions in the incidence of SSI after vascular surgery has been questioned and the success of the parent initiatives in reducing SSI-related hospital readmission is unknown, at the very least, these measures reflect a mature framework for future efforts to mitigate the impact of SSI in the vascular surgery population. 28, 29 Numerous approaches for minimizing the incidence of perioperative stroke during CEA have also been described. To date, perioperative antiplatelet therapy is the only evidence-based process measure for perioperative stroke prevention during CEA that has been endorsed by the National Quality Forum. 30, 31 Other adjuncts, such as intraoperative shunting and intraoperative neurophysiologic monitoring, are unlikely to gain consensus as process measures within the vascular surgery community because the evidence supporting the efficacy of the techniques is far from uniform. 32, 33 Because most of the risk factors for this complication appear to be related to patient and disease factors and on not perioperative conduct, future implementation of additional process measures that target perioperative stroke may not be feasible. 34 However, use of the risk-adjusted perioperative stroke rate to identify potential hospital or surgeon "outliers" would appear to be justified on the basis of the complication's impact on the CEA population. Use of stroke rate as an outcome measure is further supported by the emphasis given to this parameter in current guidelines for the management of carotid artery stenosis. 35, 36 A strong foundation also exists for the development of initiatives that are designed to reduce the incidence of pneumonia after major vascular surgery. Numerous strategies for the postoperative prevention of pneumonia have been described, including preoperative respiratory muscle training, intraoperative use of low-volume mechanical ventilation, preferential use of epidural rather than systemic analgesia in the early postoperative period, and selective use of continuous positive airway pressure after intubation. [37] [38] [39] [40] Each of these strategies has at least some level of evidence to support its use in the general surgical population. In addition, several hospitals have observed a reduction in their incidence of postoperative pneumonia after the implementation of specific multidisciplinary pneumonia-prevention bundles. 41, 42 Although the potential benefits of these strategies or programs has not been assessed specifically in the vascular surgery population, such patients represent an excellent substrate for further evaluation of processes of care that are intended to reduce the incidence of this pneumonia. 43 Prevention of bleeding complications after vascular surgery may prove more challenging. Obvious strategies for reducing the incidence of this complication include preoperative cessation of nonessential antiplatelet agents and intraoperative administration of protamine sulfate for heparin reversal. 44, 45 Although there is some concern that these measures will subject vascular surgery patients to a greater risk of postoperative thrombotic events, the results of our analysis suggest that bleeding has greater overall patient impact than MI or CVA. In addition, whether the negative impact of postoperative bleeding is due primarily to the ill consequences of organ hypoperfusion or instead to the deleterious effects of ensuing blood transfusion is not entirely clear. 46 The clinical burden that is imposed by bleeding complications may possibly be reduced by adopting more stringent blood transfusion thresholds or by improving the timeliness of definitive intervention in patients who sustain postoperative hemorrhage. Finally, to the extent that postoperative bleeding may be a function of intraoperative technical error, it may also be possible to adopt a more structural approach towards bleeding prevention such as comprehensive surgical coaching, intraoperative formative assessment, and improvement programs. 47 Given the heavy clinical and economic burden that bleeding complications impose on the vascular surgery population, further investigation into optimal perioperative anticoagulation strategies, ideal transfusion thresholds, and influence of technical performance on this complication appear warranted.
As for existing quality initiatives, the results of our study suggest that the current federal approach to complication-related surgical quality improvement will have little if any effect on early clinical and economic outcomes after major vascular surgery. This approach is largely based on SCIP, a national quality collaborative that was first implemented in 2006 by the Centers for Medicare and Medicaid Services, the Joint Commission, and other stakeholder organizations. 27 SCIP originally consisted of a number of processes of care measures that were believed to be important for the prevention of postoperative SSI, VTE, and MI. With the addition of UTI, these same complications remain the focus of more recent federal quality efforts such as the Hospital Compare public reporting program and the Hospital Value-Based Purchasing Program. 48, 49 Aside from the sizeable impact of SSI on readmission and the modest impact of MI on mortality, the relevance of SCIP complications to vascular surgery patients appears to be limited. Continued application of UTI-and VTE-related processes of care to vascular surgery patients will therefore result in an inefficient allocation of health care quality improvement resources, diverting these presumably finite resources away from the complications that matter the most to this patient population.
Our study has several important limitations. First, we did not have information about procedure-specific complications, such as vascular graft thrombosis or ischemic colitis, and are therefore precluded from estimating the impact of these types of complications relative to the more generic complications analyzed in our study.
Second, we did not examine the clinical or economic impact of complications >30 postoperative days. We thus could have underestimated the clinical outcome of complications such as SSI that may portend later events such as vascular graft infection.
Third, we hypothesized complete prevention of index complications in our estimation of risk-adjusted PAFs. This hypothetical assumption was chosen to highlight the maximum impact that each complication has on the outcome measures of our study. Whether certain complications may be more easily prevented than others, and thus be more amenable to quality modification, is unknown.
Finally, complications such as bleeding may not be preventable in certain patients who require emergency vascular operation. Nevertheless, because federal stakeholders do not appear to exclude emergency operations from their complication-associated quality metrics, we included these patients in our analysis.
Despite these limitations, our study represents the first published attempt to rank postoperative vascular surgery complications according to their overall 30-day clinical and economic impacts. By identifying bleeding, pneumonia, and SSI as high-impact complications, our study provides a framework for the development of quality initiatives that are designed to reduce the burden that complications impose on the vascular surgery population.
CONCLUSIONS
This work demonstrates that current national health care quality improvement initiatives do not target the complications that are most important to vascular surgical patient outcomes. To prevent high-impact postoperative complications in the vascular population, improvement efforts need to be focused on bleeding, pneumonia, and SSI. 
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